Alemtuzumab as a novel treatment for refractory giant cell myocarditis after heart transplantation.
Transplant Unit.
Jonathan D W
JD
Evans
Transplant Unit.
Stephen J
SJ
Pettit
Pathology Department, Papworth Hospital National Health Service Foundation Trust, Papworth Everard, Cambridge, United Kingdom.
Martin
M
Goddard
Transplant Unit.
Clive
C
Lewis
Transplant Unit.
Jayan K
JK
Parameshwar
D000328:Adult; D000074323:Alemtuzumab; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D015726:Giant Cells / Q000473:pathology; D016027:Heart Transplantation; D006801:Humans; D008297:Male; D009205:Myocarditis / Q000188:drug therapy* / Q000209:etiology / Q000473:pathology; D011183:Postoperative Complications; D012008:Recurrence
D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D000074323:Alemtuzumab